Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells

Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells

Gespeichert in:

Bibliographische Detailangaben
Datum:	2015
Hauptverfasser:	V. F. Chekhun, I. V. Zalutskii, L. A. Naleskina, Yu. Lukianova, T. M. Yalovenko, T. V. Borikun, S. O. Sobchenko, I. V. Semak, V. S. Lukashevich
Format:	Artikel
Sprache:	English
Veröffentlicht:	2015
Schriftenreihe:	Experimental Oncology
Online Zugang:	http://jnas.nbuv.gov.ua/article/UJRN-0000467526
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:	Library portal of National Academy of Sciences of Ukraine \| LibNAS

Institution

Library portal of National Academy of Sciences of Ukraine | LibNAS

Ähnliche Einträge

Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
von: Chekhun, V.F., et al.
Veröffentlicht: (2015)

Effects of exogenous lactoferrin on phenotypic profile and invasiveness of human prostate cancer cells (DU145 and LNCaP) in vitro
von: Zadvornyi, T.V., et al.
Veröffentlicht: (2018)

Influence of exogenous lactoferrin on the oxidant/ antioxidant balance and molecular profile of hormone receptor-positive and -negative human breast cancer cells in vitro
von: Zalutski, I.V., et al.
Veröffentlicht: (2017)

Lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease
von: Naleskina, L.A., et al.
Veröffentlicht: (2016)

Features of hepcidin expression in patients with breast cancer
von: Yu. Lukianova, et al.
Veröffentlicht: (2015)

Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
von: S. V. Chekhun, et al.
Veröffentlicht: (2014)

Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
von: Chekhun, S.V., et al.
Veröffentlicht: (2014)

Molecular-genetic bases of clinical heterogeneity of breast cancer (literature review)
von: L. A. Nalieskina, et al.
Veröffentlicht: (2017)

The value of iodide symporter for prognosis of breast cancer of different molecular subtypes
von: Yu. Lukianova, et al.
Veröffentlicht: (2017)

Features of architectonics of neoplasms and molecular profile of tumor cells in patients with breast cancer
von: L. A. Nalieskina, et al.
Veröffentlicht: (2018)

Effect of 5-azacytidine on miRNA expression in human breast cancer cells with different sensitivity to cytostatics
von: V. F. Chekhun, et al.
Veröffentlicht: (2016)

Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
von: Chekhun, V.F., et al.
Veröffentlicht: (2016)

Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
von: Lukianova, N.Yu., et al.
Veröffentlicht: (2023)

Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics
von: Chekhun, V.F., et al.
Veröffentlicht: (2017)

Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
von: S. Chekhun, et al.
Veröffentlicht: (2013)

Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
von: Chekhun, S., et al.
Veröffentlicht: (2013)

Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing rats
von: Chekhun, V.F., et al.
Veröffentlicht: (2018)

EpCAM expression in breast tumor cells and their relation to clinical and pathological parameters and molecular subtype of cancer
von: L. M. Kovalevska, et al.
Veröffentlicht: (2019)

Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
von: Yalovenko, T.M., et al.
Veröffentlicht: (2016)

Association of circulating miR-21, -205, and -182 with response of luminal breast cancers to neoadjuvant FAC and AC treatment
von: Chekhun, V.F., et al.
Veröffentlicht: (2023)

The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
von: Todor, I.N., et al.
Veröffentlicht: (2012)

SD44+/CD24? markers of cancer stem cells in patients with breast cancer of different molecular subtypes
von: S. V. Chekhun, et al.
Veröffentlicht: (2015)

Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome
von: Grybach, S.M., et al.
Veröffentlicht: (2018)

Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome
von: Grybach, S.M., et al.
Veröffentlicht: (2018)

СD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes
von: Chekhun, S.V., et al.
Veröffentlicht: (2015)

The influence of lactoferrin on elemental homeostasis and activity of metal-containing enzymes in rats with Walker-256 carcinosarcoma
von: Lozovska, Yu.V., et al.
Veröffentlicht: (2023)

Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
von: Lukianova, N.Yu., et al.
Veröffentlicht: (2016)

The Clinical Significance of Tumor MIR-122, -155, -182, and -200b Expression in Patients with Breast Cancer
von: V. F. Chekhun, et al.
Veröffentlicht: (2017)

Influence of ferromagnetic nanocomposite (Ferroplat) on human breast cancer cells of different malignancy degrees: pro/antioxidant balance and energy metabolism
von: Chekhun, V.F., et al.
Veröffentlicht: (2018)

Expression of CD44 with the progression of the tumor process of breast cancer patients with metabolic syndrome
von: S. M. Hrybach, et al.
Veröffentlicht: (2018)

Genetic modifiers of spinal muscular atrophy phenotype
von: N. V. Grishchenko, et al.
Veröffentlicht: (2020)

Clinicopathological features of nonspecific invasive breast cancer according to its molecular subtypes
von: Zavyalova, M., et al.
Veröffentlicht: (2016)

Association of cd44⁺cd24⁻/low with markers of aggressiveness and plasticity of cell lines and tumors of patients with breast cancer
von: Chekhun, V.F., et al.
Veröffentlicht: (2017)

Hormonal-sensitive breast cancer: molecular-biological and clinical aspects of preoperative antitumor hormone therapy
von: O. V. Ponomareva
Veröffentlicht: (2018)

Significance of iodine symporter for prognosis of the disease course and efficacy of neoadjuvant chemotherapy in patients with breast cancer of luminal and basal subtypes
von: Chekhun, V.F., et al.
Veröffentlicht: (2017)

Comparative study of dye-loaded liposome accumulation in sensitive and resistant human breast cancer cells
von: Yefimova, S.L., et al.
Veröffentlicht: (2012)

Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer
von: Timovska, Yu.O., et al.
Veröffentlicht: (2009)

Epigenetics in breast cancer
von: C. Atalay
Veröffentlicht: (2013)

Epigenetics in breast cancer
von: Atalay, C.
Veröffentlicht: (2013)

Molecular phenotype of high-grade endometrioid carcinoma of the endometrium
von: Buchynska, L.G., et al.
Veröffentlicht: (2023)